Daewoong pharmaceutical

069620.KO

85.66 USD

-1.12

-1.29%

Overview

Last close

85.66 usd

Market cap

985.68M usd

52 week high

119.37 usd

52 week low

72.17 usd

Target price

133.64 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.0297

Price/Book Value

1.7724

Enterprise Value

1.32B usd

EV/Revenue

1.363

EV/EBITDA

11.6175

Key financials

Revenue TTM

958.79M usd

Gross Profit TTM

437.30M usd

EBITDA TTM

119.98M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

1,877.36B usd

Net debt

N/A usd

About

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.